Hiroshi Fuji Selected Research

DNA (Deoxyribonucleic Acid)

9/2002

DNA alkylating agents alleviate silencing of class II transactivator gene expression in L1210 lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Fuji Research Topics

Disease

18	Neoplasms (Cancer) 02/2024 - 10/2005
3	Prostatic Neoplasms (Prostate Cancer) 10/2011 - 06/2005
2	Brain Neoplasms (Brain Tumor) 02/2024 - 06/2019
2	Neuroblastoma 08/2020 - 11/2013
2	Hepatoblastoma 01/2020 - 12/2017
2	Neoplasm Metastasis (Metastasis) 12/2017 - 02/2015
2	Lymphoma (Lymphomas) 09/2009 - 09/2002
1	Necrosis 02/2024
1	Central Nervous System Neoplasms 02/2024
1	Germinoma 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 07/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2021
1	Leukemia 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2019
1	Chronic Granulomatous Disease 01/2019
1	Rhabdomyosarcoma 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Poliomyelitis (Polio) 12/2014
1	Paraparesis 12/2014
1	Melanoma (Melanoma, Malignant) 07/2014
1	Medulloblastoma 03/2014
1	Hearing Loss (Hearing Impairment) 03/2014
1	Respiratory Insufficiency (Respiratory Failure) 09/2012
1	Chordoma 05/2011
1	Chondrosarcoma 05/2011
1	Radiation Pneumonitis 05/2010
1	Esophageal Neoplasms (Esophageal Cancer) 05/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2009
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2008
1	Lower Urinary Tract Symptoms 12/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2003

Drug/Important Bio-Agent (IBA)

6	Protons (Proton)IBA 01/2018 - 10/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2010
1	TinIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	pirarubicinIBA 01/2020
1	Busulfan (Busulfex)FDA Link 01/2019
1	Voriconazole (Vfend)FDA LinkGeneric 09/2012
1	Micafungin (FK463)FDA Link 09/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2012
1	Itraconazole (Sporanox)FDA LinkGeneric 09/2012
1	Fluorouracil (Carac)FDA LinkGeneric 05/2010
1	AntigensIBA 09/2009
1	silodosin FDA Link 12/2008
1	Docetaxel (Taxotere)FDA Link 11/2006
1	DNA (Deoxyribonucleic Acid)IBA 09/2002
1	Alkylating AgentsIBA 09/2002
1	MHC class II transactivator proteinIBA 09/2002

Therapy/Procedure

16	Radiotherapy 02/2024 - 06/2005
15	Proton Therapy 07/2021 - 10/2005
7	Drug Therapy (Chemotherapy) 01/2022 - 03/2003
2	Induction Chemotherapy 08/2020 - 12/2017
2	Chemoradiotherapy 02/2015 - 05/2010
2	Drug Tapering 03/2014 - 11/2013
2	Brachytherapy 06/2005 - 03/2003
1	Re-Irradiation 02/2024
1	Nephroureterectomy 01/2021
1	Combined Modality Therapy 08/2020
1	Hepatectomy 11/2019
1	Homologous Transplantation 01/2019
1	Metastasectomy 12/2017
1	Argon Plasma Coagulation 02/2015
1	Lymph Node Excision (Lymph Node Dissection) 12/2014
1	Proctectomy 12/2014
1	Aftercare (After-Treatment) 03/2014
1	Therapeutics 09/2012
1	Synchrotrons 11/2009